Re: "Merck was knocking at their door"
“We sit here today looking backward, saying, ‘It only took two years.’ So, it's not delayed versus what would have been a normal expectation. We just weren't across the finish line as quickly as some of the other players,” she (Taylor) said.
That pretty much sums up Novavax's view of the world and why the stock is at $5. Taylor and other Executives made millions during the pandemic, but long term investors lost fortunes. She and the rest of the Executives are tone deaf to the investors that kept Novavax afloat during the very lean years. They think they did a great job getting Nuvaxovid partially approved in two years, but THEY MISSED THE PANDEMIC and the profits that went with it.
Jacobs should get rid of Taylor, Trizzino and everyone else responsible for such an epic Operational failure. Go back to being a sub-1000 person company working on new vaccines and perfecting the manufacturing process for the CIC.